ArticleHealth science reports2026
A Scoping Review Protocol of Lung Ultrasound in Pediatric COVID-19: Clinical Utility and Lessons for Future Pandemics.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Lung ultrasound (LUS) is an ultrasound-based procedure used to evaluate thoracic structures, including the pleura and lung parenchyma. It has become an increasingly important tool for diagnosing and monitoring respiratory diseases, including in pediatric populations. The recent COVID-19 pandemic had created unprecedented challenges in respiratory diagnosis and care, accelerating the use of LUS as a rapid, practical, and safe examination method, particularly suitable for children. This scoping review aims to map and synthesize evidence on the use of LUS in pediatric COVID-19, identify research gaps, and inform future studies. Methods: This review will be conducted in accordance with JBI methodological guidance for scoping reviews and reported by following the preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews (PRISMA-ScR) checklist. Our strategy will search on major databases, including MEDLINE, Embase, Web of Science, Scopus, and CINAHL, and gray literatures resources. Assessment of the studies will be performed by two independent reviewers against the inclusion criteria. Eligible studies will include pediatric populations (< 18 years) with suspected, confirmed, or recovered COVID-19, assessing LUS for respiratory evaluation. Studies of any design, language, and methodological quality published from December 2019 onward will be considered. Data will be extracted and synthesized in line with scoping review methodology. Results: Evidence will be synthesized using a primarily deductive approach with inductive flexibility to identify emerging themes, including clinical applications of LUS, protocols of imaging acquisition and interpretation, and study designs. Findings will be mapped and presented in tables and summarized narratively. Conclusion: This review will provide a comprehensive overview of LUS use in pediatric COVID-19, supporting its integration into clinical practice and informing preparedness for future respiratory outbreaks. Scoping Review Registration: This protocol was registered in Open Science Framework on July 30, 2025 (https://doi.org/10.17605/OSF.IO/XP628).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.